- Home
- NERV vs HWH Comparison
NERV vs HWH Comparison
Compare NERV & HWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- HWH
- Stock Information
- Founded
- NERV 2007
- HWH 2021
- Country
- NERV United States
- HWH United States
- Employees
- NERV N/A
- HWH N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- HWH Other Pharmaceuticals
- Sector
- NERV Health Care
- HWH Health Care
- Exchange
- NERV Nasdaq
- HWH Nasdaq
- Market Cap
- NERV 12.0M
- HWH 10.1M
- IPO Year
- NERV 2014
- HWH N/A
- Fundamental
- Price
- NERV $2.15
- HWH $2.70
- Analyst Decision
- NERV Hold
- HWH
- Analyst Count
- NERV 1
- HWH 0
- Target Price
- NERV $5.00
- HWH N/A
- AVG Volume (30 Days)
- NERV 12.9K
- HWH 19.3M
- Earning Date
- NERV 11-04-2025
- HWH 11-11-2025
- Dividend Yield
- NERV N/A
- HWH N/A
- EPS Growth
- NERV N/A
- HWH N/A
- EPS
- NERV 1.48
- HWH N/A
- Revenue
- NERV N/A
- HWH $1,238,173.00
- Revenue This Year
- NERV N/A
- HWH N/A
- Revenue Next Year
- NERV N/A
- HWH N/A
- P/E Ratio
- NERV $1.46
- HWH N/A
- Revenue Growth
- NERV N/A
- HWH 17.28
- 52 Week Low
- NERV $1.15
- HWH $0.90
- 52 Week High
- NERV $2.98
- HWH $7.77
- Technical
- Relative Strength Index (RSI)
- NERV 48.19
- HWH 48.82
- Support Level
- NERV $2.06
- HWH $2.82
- Resistance Level
- NERV $2.25
- HWH $7.16
- Average True Range (ATR)
- NERV 0.11
- HWH 1.22
- MACD
- NERV -0.03
- HWH -0.18
- Stochastic Oscillator
- NERV 24.19
- HWH 20.41
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About HWH HWH International Inc.
HWH International Inc is and its consolidated subsidiaries operate a food and beverage business in Singapore and South Korea. The F&B business operates four cafes, two of which are located in South Korea and two in Singapore, as well as an online healthy food store, serving customers in Singapore.